More than 30 Spanish companies present at the BIO International Convention, the world's leading event for biotechnology

The United States, a key market for Spanish biotechnology

A total of 32 Spanish companies and institutions participate in the Spain Pavilion, demonstrating the growing potential of the Spanish biotechnology sector and its commitment to internationalization.

---

 

Spain appears strongly in the BIO International Convention 2024, the world's leading event for the biotechnology industry held in San Diego from 3 to 6 in June.

 

La BIO International Convention It offers an ideal platform for Spanish companies and entities to make their offer known to the main players in the biotechnology sector worldwide. The event provides access to information of high scientific, financial and commercial value, as well as the possibility of closing strategic alliances, obtaining financing and obtaining new clients.

 

The extensive program of the BIO International Convention includes academic activities, company presentations, seminars and conferences on the latest trends in biotechnology, career development opportunities, and much more. One of the keys to the event's success is the partnering system, which allows participants to schedule one-on-one meetings with other participants. companies and institutions.

 

The United States is the largest biopharmaceutical market in the world and triples the volume of the European biotechnology industry

 

More and more Spanish companies are making the leap to the North American market, thanks to technological and commercial collaboration agreements with American companies. The presence of companies such as Oryzon, Sanifit, Pharmamar or Grifols in the US It is a clear example of the Spanish potential in this sector.

 

Despite being a smaller market compared to the North American market, the United States recognizes high scientific and research quality in the Spanish sector, both in basic research and in applied research and clinical diagnosis. The main therapeutic areas of interest for this market are oncology, neurodegenerative and inflammatory diseases, vaccines, advanced therapies and rare diseases.

 

The growing presence of Spanish biotechnology companies in the US is helping to improve and consolidate Spain's image as a leading country in the sector. The balance of execution of Spain's historical trajectory in this event is very positive for the Spanish biotechnology industry, which is increasingly overcoming limitations in terms of size and financial resources to launch its commercial and research activity in the United States. .